TD Asset Management Inc

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1056053 Toronto, A6

Position in CRNX

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$8,531,277

-$335,473 QoQ

Shares Held

234,892

+23.3% QoQ

Ownership

0.223%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

TD Asset Management Inc holds $1,314,505,240 across 121 Biotechnology names. CRNX ranks #34 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	350,923	$271,137,146
2	VRTX	Vertex Pharmaceuticals Inc / Ma	228,195	$101,898,194
3	ALNY	Alnylam Pharmaceuticals, Inc.	281,848	$93,255,047
4	HALO	Halozyme Therapeutics, Inc.	1,168,666	$75,530,883
5	ARGX	Argenx SE	80,824	$59,021,726
6	ASND	Ascendis Pharma A/S	217,992	$49,861,310
7	IONS	Ionis Pharmaceuticals Inc	529,954	$39,794,245
8	RVMD	Revolution Medicines, Inc.	317,811	$30,907,119

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,531,277	234,892	+23.3%	Shares	Sole	2026-05-11
2025-12-31	$8,866,750	190,478	-6.4%	Shares	Sole	2026-02-10
2025-09-30	$8,477,774	203,548	+0.5%	Shares	Sole	2025-11-10
2025-06-30	$5,823,382	202,482	+15.9%	Shares	Sole	2025-07-28
2025-03-31	$5,859,236	174,694	-23.7%	Shares	Sole	2025-05-07
2024-12-31	$11,708,974	229,004	+9.0%	Shares	Sole	2025-02-11
2024-09-30	$10,737,234	210,122	+2.5%	Shares	Sole	2024-11-01
2024-06-30	$9,181,860	204,998	-12.8%	Shares	Sole	2024-08-02
2024-03-31	$11,009,618	235,198	+33.3%	Shares	Sole	2024-05-08
2023-12-31	$6,277,237	176,426	+26.5%	Shares	Sole	2024-02-12
2023-09-30	$4,146,529	139,426	+136.7%	Shares	Sole	2023-10-27
2023-06-30	$1,061,378	58,900	+113.4%	Shares	Sole	2023-08-09
2023-03-31	$443,256	27,600	—	Shares	Sole	2023-05-10
No filing history on record for this holder in this stock.